- Previous Close
2,600.00 - Open
2,600.00 - Bid 2,700.00 x --
- Ask 2,600.00 x --
- Day's Range
2,590.00 - 2,660.00 - 52 Week Range
1,545.00 - 3,510.00 - Volume
403,200 - Avg. Volume
285,516 - Market Cap (intraday)
32.556T - Beta (5Y Monthly) 0.29
- PE Ratio (TTM)
-- - EPS (TTM)
-2.13 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia. It operates and manages hospitals under the Mayapada Hospital name for neuroscience center, uro-nephrology center, cardiovascular center, gastro hepatology center, gastrointestinal and liver center, oncology center, orthopedic center, spine and arthroplasty center, obstetrics and gynecology center, internal medicine and pulmonology, pediatric center, dermato and aesthetic clinic, sports injury treatment and performance center, post covid recovery and rehabilitation center, and allergy and immunology center. The company was formerly known as PT Sejahtera Raya Anugrah and changed its name to PT Sejahteraraya Anugrahjaya Tbk in December 1992. PT Sejahteraraya Anugrahjaya Tbk was founded in 1991 and is based in Tangerang, Indonesia. PT Sejahteraraya Anugrahjaya Tbk is a subsidiary of PT Surya Cipta Inti Cemerlang.
www.mayapadahospital.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SRAJ.JK
View MorePerformance Overview: SRAJ.JK
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SRAJ.JK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SRAJ.JK
View MoreValuation Measures
Market Cap
31.82T
Enterprise Value
33.21T
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.91
Price/Book (mrq)
17.37
Enterprise Value/Revenue
10.55
Enterprise Value/EBITDA
130.89
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.75%
Return on Assets (ttm)
2.02%
Return on Equity (ttm)
-1.26%
Revenue (ttm)
3.15T
Net Income Avi to Common (ttm)
-23.51B
Diluted EPS (ttm)
-2.13
Balance Sheet and Cash Flow
Total Cash (mrq)
277.21B
Total Debt/Equity (mrq)
173.53%
Levered Free Cash Flow (ttm)
-217.22B